NL-OMON43203已完成不适用
Circulating tumor DNA as a biomarker in perihilar cholangiocarcinoma: a feasibility study - circulating tumor DNA in perihilar cholangiocarcinoma
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •-Patients older than 18 years
- •-Undergoing explorative laparotomy, diagnostic laparoscopy or percutaneous biopsy
- •-Able to understand the information given and provide written informed consent
排除标准
- •-18 years or younger
- •-Unfit for laparotomy/ diagnostic laparoscopy/ biopsies or blood analyses in palliative
- •chemotherapy studies
- •-HIV/AIDS/hepatitis C in medical history
- •-Not able to give informed consent (language, intellectual capacities, etc.)
研究者
相似试验
尚未招募
不适用
Circulating tumor DNA as biomarker for perihilar cholangiocarcinomaPerihilar cholangiocarcinoma/ Perihilair cholangiocarcinoomKlatskin-tumorBiomarkerCirculating tumor DNA /Circulerend tumor DNA (ctDNA)NL-OMON27478AMC20
招募中
不适用
Circulating tumor DNA as a noninvasive biomarker in patients with thyroid cancerC73Malignant neoplasm of thyroid glandDRKS00022441niversitätsklinikum Freiburg75
招募中
不适用
Circulating tumor DNA as a noninvasive biomarker in patients with Non-Hodgkin Lymphoma (NHL)C83.3C85Diffuse large B-cell lymphomaOther and unspecified types of non-Hodgkin lymphomaDRKS00024180niversitätsklinikum Freiburg200
招募中
不适用
Circulating Tumour DNA in Stage 1 to 4 Ovarian CancerOvarian cancerACTRN12617001119381Walter and Eliza Hall Institute of Medical Research100
尚未招募
不适用
Circulating Tumour DNA as a Marker of Complete Pathological Response and Long Term Outcome for Locally Advanced Rectal Cancer Treated with Pre-operative ChemoradiotherapyACTRN12612000327886udwig Institute for Cancer Research320